- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier sponset av Liaoning Cancer Hospital & Institute
Totalt 3933 resultater
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåPositron-utslippstomografi
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringHER2-positiv metastatisk brystkreft | Tidligere behandlet med Trastuzumab | Trastuzumab kombinert med Pertuzumab og kjemoterapiKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennå
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringHER2 positive eller mistenkelige positive svulsterKina
-
Peking University Cancer Hospital & InstituteRekrutteringGastrisk adenokarsinomKina
-
Peking University Cancer Hospital & InstituteFullførtTykktarmskreft | Kirurgi | Levermetastaser | Minimal restsykdom | Sirkulerende tumor-DNAKina
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteFullført
-
Shandong Cancer Hospital and InstituteAvsluttetIkke-småcellet lungekreftKina
-
Peking University Cancer Hospital & InstituteUkjentAvansert ikke-plateepitel, ikke-småcellet lungekreftKina
-
Peking University Cancer Hospital & InstituteUkjentBukspyttkjertelkreft | Gastrisk adenokarsinom | Kolangiokarsinom | HER2-negativ brystkreftKina
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteFullført
-
Peking University Cancer Hospital & InstituteUkjentQOL; Livskvalitet; Magekreft; Gastrectomy; Neoadjuvant kjemoterapiKina
-
Peking University Cancer Hospital & InstituteUkjentLymfom | Positron-utslippstomografi | Svulst, solidKina
-
Peking University Cancer Hospital & InstituteUkjent
-
Peking University Cancer Hospital & InstituteUkjentAvansert slimhinnemelanomKina
-
Shandong Cancer Hospital and InstituteFullførtNeoplasmer i spiserøretKina
-
Shandong Cancer Hospital and InstituteAvsluttetNeoplasmer i spiserøretKina
-
Peking University Cancer Hospital & InstituteUkjentKarsinom, ikke-småcellet lunge | Docetaxel | NivolumabKina
-
Shandong Cancer Hospital and InstituteUkjentBrystneoplasmer | Dermatitt | Forebygging og kontroll | Epigallocatechin Gallate
-
Peking University Cancer Hospital & InstituteUkjentTilbakevendende småcellet lungekreftKina
-
Peking University Cancer Hospital & InstituteUkjent
-
Peking University Cancer Hospital & InstituteUkjentAvansert melanomKina
-
Peking University Cancer Hospital & InstituteUkjentHepatocellulært karsinomKina
-
Peking University Cancer Hospital & InstituteUkjentMetastatisk nyrecellekarsinomKina
-
Shandong Cancer Hospital and InstituteUkjentMetastatisk brystkreft
-
Peking University Cancer Hospital & InstituteFullførtBrystneoplasmer | Neoplasma MetastaseKina
-
Peking University Cancer Hospital & InstituteUkjentMelanom | Neoplasma Metastase | TOR serin-treoninkinaserKina
-
Shandong Cancer Hospital and InstituteUkjentKarsinom, hepatocellulært | FENYTOIN/SORAFENIB [VA medikamentinteraksjon]Kina
-
Peking University Cancer Hospital & InstituteRekrutteringEgglederkarsinom | Ovariekarsinom | Primært peritonealt karsinomKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Shandong Cancer Hospital and InstituteRekrutteringIntrahepatisk kolangiokarsinomKina
-
Shandong Cancer Hospital and InstituteRekrutteringTykktarmskreft | Strålebehandling | Immunterapi | Målrettet terapiKina
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåMagekreft | Kreft i spiserøret | Risikostratifisering | Presisjonsscreening | Sekvensiell screeningKina
-
Shandong Cancer Hospital and InstituteRekruttering
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennå
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåHER2-positiv tykktarmskreft | HER2-positiv galleveiskreftKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringLevermetastase Tykktarmskreft | Avansert kolorektalt karsinomKina
-
Peking University Cancer Hospital & InstituteRekrutteringIkke småcellet lungekreftKina
-
Shandong Cancer Hospital and InstituteRekrutteringAvansert esophageal plateepitelkreftKina